FormWeb • quiNIDine

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

quiNIDine

quiNIDine

Formulary

Drug Name	Form	Strength
quiNIDine gluconate	SOLUTION, INJECTABLE	80 mg/mL
QUINAGLUTE DURA	TABLET, EXTENDED RELEASE, ORAL	324 mg
quiNIDine sulfate	TABLET, ORAL	200 mg, 300 mg

VIEW MORE Class Ia Antiarrhythmics
CLASS

Comments:

CDC Recommendation as of January 2019:

For emergent treatment of severe complicated malaria, the CDC is currently recommending artesunate. This agent is not yet approved by the FDA in the US, but is available from the CDC on an emergency basis if needed.

Updated: January 2019 (IV quiNIDine gluconate manufacturer discontinued)

Last updated: Nov. 16, 2022

Black Box Warning: Active antiarrhythmic therapy may increase mortality
Formulary, Not Routinely Stocked: QUINAGLUTE DURA --> 324 mg extended release tablet

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.